Overview
Joao Carneiro practices practicing medicine in Porto, Portugal.
His clinical expertise encompasses PMM2-Congenital Disorder of Glycosylation and Ebola Virus Disease.
He is actively involved in clinical research, co-authoring 28 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Joao F. Carneiro
Is Joao F. Carneiro a top-rated expert for PMM2-Congenital Disorder of Glycosylation?
MediFind is an objective health platform that identifies experts based on real-world data. Joao F. Carneiro is classified as an Experienced expert for PMM2-Congenital Disorder of Glycosylation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Joao F. Carneiro participate in research or clinical trials?
Yes. Joao F. Carneiro has published 28 articles and abstracts on conditions like PMM2-Congenital Disorder of Glycosylation. You can view a list of Joao F. Carneiro's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ebola Virus DiseaseMr. Carneiro isExperienced. Learn about Ebola Virus Disease.
- PMM2-Congenital Disorder of GlycosylationMr. Carneiro isExperienced. Learn about PMM2-Congenital Disorder of Glycosylation.